New combo attack on breast cancer brain tumors
NCT ID NCT03807765
Summary
This early-phase study tested whether combining a precise form of radiation (stereotactic radiosurgery) with an immunotherapy drug (nivolumab) is safe and can help control breast cancer that has spread to the brain. It involved 14 adults with metastatic breast cancer and brain tumors. The main goal was to check for serious side effects, especially in the brain, while also seeing if the treatment could slow the cancer's growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.